Neuro-Oncological Ventral Antigen

They are RNA-BINDING PROTEINS involved in mRNA processing. These are essential in gene regulation, including splicing, translation, transport, stability, and degradation of RNA.

Also Known As:

1, Nova; Antigen, Neuro-Oncological Ventral; Antigen, Nova; Antigen, Nova-1; Antigen, Paraneoplastic Ri; Antigen, Ri; Neuro Oncological Ventral Antigen; Neuro Oncological Ventral Antigen 2; Nova 1 Antigen; Protein, Nova; Ri Antigen, Paraneoplastic; Ri Antigens; Ventral Neuron Specific Protein 1; Antigens, Ri; Neuro-Oncological Ventral Antigen 1; Neuro-Oncological Ventral Antigen 2; Nova 1; Nova Antigen; Nova Protein; Nova-1 Antigen; Paraneoplastic Ri Antigen; Paraneoplastic Ri Antigen, 55 KDA; Ri Antigen; Ventral Neuron-Specific Protein 1

Networked: 14 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Bai, Yongyi: 1 article (01/2022)
2.	Deng, Xinxin: 1 article (01/2022)
3.	Guan, Quan-Lin: 1 article (01/2022)
4.	Hu, Chen-Xiao: 1 article (01/2022)
5.	Li, Dongyun: 1 article (01/2022)
6.	Ran, Jun-Tao: 1 article (01/2022)
7.	Shen, Mingzhi: 1 article (01/2022)
8.	Su, Fei: 1 article (01/2022)
9.	Su, Hong-Xin: 1 article (01/2022)
10.	Yang, Gang: 1 article (01/2022)

Related Diseases

1.	Glioblastoma (Glioblastoma Multiforme) 01/01/2019 - "The current study aimed to investigate whether miR-193a-5p influences cell proliferation and migration through the mitogen-activated protein kinase/extracellular signal-regulated kinase signaling pathway by targeting neuro-oncological ventral antigen 1 (NOVA1) in glioblastoma. "
2.	Brain Ischemia (Cerebral Ischemia) 01/01/2013 - "The present study aimed to evaluate the expression of neuro-oncological ventral antigen 1 (Nova1) in cerebral ischemia/reperfusion (I/R) insults by immunohistochemistry. " 01/01/2013 - "Dynamic expression pattern of neuro-oncological ventral antigen 1 (Nova1) in the rat brain after focal cerebral ischemia/reperfusion insults."
3.	Tertiary Lymphoid Structures 03/01/2016 - "Recent studies have revealed that the splicing factor neuro-oncological ventral antigen 1 (NOVA1) is enriched in fibroblasts and accumulated T cells of tertiary lymphoid structures. "
4.	Neoplasms (Cancer) 08/01/2017 - "Neuro-oncological ventral antigen 1 (NOVA1): Implications in neurological diseases and cancers." 04/15/2001 - "The target Ri antigen was found to be expressed by the tumor. " 01/01/2014 - "Neuro-oncological ventral antigen 1 (Nova1) is a neuron-specific RNA-binding protein in human paraneoplastic opsoclonus-myoclonus ataxia accompanying with malignant tumors, but its role in hepatocellular carcinoma (HCC) remains elusive. "
5.	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/01/2020 - "The neuro-oncological ventral antigen 2 (NOVA2) protein is a major factor regulating neuron-specific alternative splicing (AS), previously associated with an acquired neurologic condition, the paraneoplastic opsoclonus-myoclonus ataxia (POMA). " 01/01/2014 - "Neuro-oncological ventral antigen 1 (Nova1) is a neuron-specific RNA-binding protein in human paraneoplastic opsoclonus-myoclonus ataxia accompanying with malignant tumors, but its role in hepatocellular carcinoma (HCC) remains elusive. "

Related Drugs and Biologics

1.	RNA Splicing Factors
2.	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
3.	Mitogen-Activated Protein Kinases
4.	RNA-Binding Proteins (RNA-Binding Protein)
5.	Proteins (Proteins, Gene)
6.	MicroRNAs (MicroRNA)
7.	Heterogeneous-Nuclear Ribonucleoprotein L
8.	Heterogeneous-Nuclear Ribonucleoprotein Group C (HNRNP C Protein)
9.	Autoantibodies
10.	Neoplasm Antigens (Tumor Antigens)